Skip to main content
Caplight Logo









Prisma Biotechnology

Prisma Biotechnology

Private
Somerville, MassachusettsHealthcare & Life Scienceshttps://www.prisma-tx.com/

Company Overview

Prisma Biotechnology is a biotechnology company that develops a protein sequencing platform designed to unveil functional drivers of biology and transform human health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

protein sequencingproteomicsdrug discoverysingle-molecule sequencingbiotech instrumentationde novo sequencingpost-translational modificationslife science toolsnext-gen proteomicsprotein analysisbiomarker discoveryomics platformdeep proteomicslab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prisma Biotechnology Comparables

Compare Prisma Biotechnology with similar companies based on industry and business-model similarity.

Prisma Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glyphic Biotechnologies
89%
Erisyon
88%
Encodia
83%

Prisma Biotechnology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Sammy Datwani

Chief Executive Officer

Executive Team

Prisma Biotechnology Filings

Explore SEC and related filing metadata, where available.

Prisma Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prisma Biotechnology's valuation, stock price, and market status.

Is Prisma Biotechnology a public or private company?

Prisma Biotechnology is a private company.

What is the current stock price of Prisma Biotechnology?

Prisma Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Prisma Biotechnology worth (valuation)?

Valuation information for Prisma Biotechnology is not publicly available.

Can I buy Prisma Biotechnology stock?

Prisma Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prisma Biotechnology's last funding round?

Funding round information for Prisma Biotechnology is not publicly available.

Who are the main investors in Prisma Biotechnology?

Investor information for Prisma Biotechnology is not publicly disclosed.

Will Prisma Biotechnology IPO soon?

No public IPO plans have been announced for Prisma Biotechnology.

How can I track Prisma Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prisma Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSomerville, Massachusetts
Employee Range6
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?